BriefCase vs INFINITT DPS

BriefCase offers mobile access for care team collaboration and is designed to integrate seamlessly into existing radiology workflows, aiming to reduce turnaround times and improve diagnostic accuracy. INFINITT DPS is web-based, providing location-independent access, but its primary focus is on pathologists reviewing whole slide images, which may imply a more specialized user base and potentially a steeper learning curve for general clinical use. Aidoc's focus on real-time AI analysis and notifications for critical findings suggests a streamlined user experience for urgent care scenarios.

Aidoc's BriefCase is FDA-cleared for multiple indications across various specialties, including stroke, PE, and ICH, with numerous clinical studies validating its impact on reducing missed findings and improving time-to-treatment. INFINITT DPS is FDA-cleared for primary diagnosis of FFPE tissue slides in pathology and has demonstrated a high diagnostic concordance rate (96.4%) with microscopic examination in a study of 557 cases. However, Aidoc's broader range of cleared indications and documented impact on critical, time-sensitive conditions across multiple clinical areas suggests a wider clinical value.

Both tools utilize an enterprise pricing model, requiring direct contact for specific quotes, which limits transparency. Aidoc's pricing starts at approximately $50,000 per site per year, with additional modules costing $8,000 to $15,000, positioning it as a premium platform for large institutions. INFINITT DPS also requires contacting them for pricing, making a direct cost comparison difficult. Without more detailed pricing information for INFINITT DPS, it's challenging to definitively declare a winner in terms of overall value for money.

Aidoc's BriefCase is designed for large hospitals and health systems, with over 500 global customers, and boasts comprehensive compliance (HIPAA, BAA, SOC2, GDPR) and seamless integration capabilities with PACS, RIS, and EHR systems. INFINITT DPS also offers high interoperability by standardizing images into DICOM format and integrating with EHR and APLIS, and is deployed in over 6,300 medical facilities globally. However, Aidoc's explicit mention of mobile apps for both iOS and Android, API availability, and a larger customer count specifically for hospitals and health systems, indicates a slightly more mature and comprehensive enterprise offering.

Aidoc's BriefCase leverages an AI-driven critical finding detection engine and focuses on real-time communication and collaboration, including mobile access and automated follow-up tracking. Aidoc also emphasizes its Clinical AI Reasoning Engine (CARE) Foundation Model and its commitment to AI transparency with model cards. INFINITT DPS offers AI-powered analysis for digital pathology and supports integration with third-party AI algorithms. While both are innovative, Aidoc's broader application of AI across various imaging modalities and its focus on an AI-powered communication platform for acute care give it an edge in innovation.

Both companies emphasize professional support. INFINITT offers 24/7 expert service and support with dedicated contact persons and proactive system monitoring. Aidoc, while not explicitly detailing its support structure in the provided information, is a mature company with a large global customer base, implying robust support and documentation. Without specific comparative details on the depth, responsiveness, or accessibility of their support and documentation, it is difficult to definitively choose a winner.